FORM OF COMPANY STOCKHOLDER SUPPORT AGREEMENT KINETA, INC.Company Stockholder Support Agreement • December 12th, 2024 • Kineta, Inc./De • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 12th, 2024 Company Industry JurisdictionTHIS SUPPORT AGREEMENT (this “Agreement”), dated as of December 11, 2024, is made by and among TuHURA Biosciences, Inc., a Nevada corporation (“Parent”), Kineta, Inc., a Delaware corporation (the “Company”), and the undersigned holder (“Stockholder”) of shares of capital stock (the “Shares”) of the Company.
EXHIBIT A-1 FORM OF COMPANY STOCKHOLDER SUPPORT AGREEMENT KINETA, INC.Company Stockholder Support Agreement • December 12th, 2024 • TuHURA Biosciences, Inc./Nv • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 12th, 2024 Company Industry JurisdictionTHIS SUPPORT AGREEMENT (this “Agreement”), dated as of December [•], 2024, is made by and among TuHURA Biosciences, Inc., a Nevada corporation (“Parent”), Kineta, Inc., a Delaware corporation (the “Company”), and the undersigned holder (“Stockholder”) of shares of capital stock (the “Shares”) of the Company.
FORM OF COMPANY STOCKHOLDER SUPPORT AGREEMENT TUHURA BIOSCIENCES, INC.Company Stockholder Support Agreement • April 3rd, 2024 • Kintara Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledApril 3rd, 2024 Company Industry JurisdictionTHIS SUPPORT AGREEMENT (this “Agreement”), dated as of April [●], 2024, is made by and among Kintara Therapeutics, Inc., a Nevada corporation (“Parent”), TuHURA Biosciences, Inc., a Delaware corporation (the “Company”), and the undersigned holder (“Stockholder”) of shares of capital stock (the “Shares”) of the Company.
FORM OF COMPANY STOCKHOLDER SUPPORT AGREEMENT TUHURA BIOSCIENCES, INC.Company Stockholder Support Agreement • April 3rd, 2024 • Kintara Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledApril 3rd, 2024 Company Industry JurisdictionTHIS SUPPORT AGREEMENT (this “Agreement”), dated as of April [●], 2024, is made by and among Kintara Therapeutics, Inc., a Nevada corporation (“Parent”), TuHURA Biosciences, Inc., a Delaware corporation (the “Company”), and the undersigned holder (“Stockholder”) of shares of capital stock (the “Shares”) of the Company.